Similar articles

• Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.

  Yu C, Rahmani M, Almenara J, Subler M, Krystal G, Conrad D, Varticovski L, Dent P, Grant S. Yu C, et al. Cancer Res. 2003 May 1;63(9):2118-26. Cancer Res. 2003. PMID: 12727828
• Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.

  Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH. Cheong JW, et al. Clin Cancer Res. 2003 Oct 15;9(13):5018-27. Clin Cancer Res. 2003. PMID: 14581377
• Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.

  Yu C, Krystal G, Varticovksi L, McKinstry R, Rahmani M, Dent P, Grant S. Yu C, et al. Cancer Res. 2002 Jan 1;62(1):188-99. Cancer Res. 2002. PMID: 11782377
• Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.

  Clarkson B, Strife A, Wisniewski D, Lambek CL, Liu C. Clarkson B, et al. Leukemia. 2003 Jul;17(7):1211-62. doi: 10.1038/sj.leu.2402912. Leukemia. 2003. PMID: 12835715 Review.
• Novel combination treatments targeting chronic myeloid leukemia stem cells.

  Al Baghdadi T, Abonour R, Boswell HS. Al Baghdadi T, et al. Clin Lymphoma Myeloma Leuk. 2012 Apr;12(2):94-105. doi: 10.1016/j.clml.2011.10.003. Epub 2011 Dec 16. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22178144 Review.